PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
  • [21] A PHASE-II TRIAL OF VINCRISTINE IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    BROUN, GO
    BLESSING, JA
    EDDY, GL
    ADELSON, MD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 18 - 21
  • [22] CIS-PLATINUM IN TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    THIGPEN, T
    SHINGLETON, H
    HOMESLEY, H
    LAGASSE, L
    BLESSING, J
    CANCER, 1981, 48 (04) : 899 - 903
  • [23] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA AND CARCINOMA OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    BEECHAM, J
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 869 - 870
  • [24] Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
    Muggia, FM
    Blessing, JA
    McGehee, R
    Monk, BJ
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 483 - 487
  • [25] PHASE-II TRIAL OF AMSA IN PATIENTS WITH ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    BONOMI, P
    BLESSING, JA
    SEDLACEK, TV
    HOMESLEY, HD
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1983, 67 (02): : 197 - 198
  • [26] Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Rose, PG
    Blessing, JA
    Arseneau, J
    GYNECOLOGIC ONCOLOGY, 1996, 62 (01) : 100 - 102
  • [27] PHASE-II TRIAL OF VP-16-213 IN THE TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE OVARY - GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    CREASMAN, WT
    PETTY, W
    BUNDY, B
    BLESSING, JA
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2089 - 2092
  • [28] PHASE-II STUDY OF MAYTANSINE IN THE TREATMENT OF ADVANCED OR RECURRENT ADENOCARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    EHRLICH, CE
    CREASMAN, WT
    CURRY, S
    BLESSING, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (03): : 273 - 275
  • [29] PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN NONSQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    DISAIA, PJ
    MCGUIRE, WP
    GYNECOLOGIC ONCOLOGY, 1993, 49 (01) : 48 - 50
  • [30] Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: A gynecologic oncology group study
    Morris, M
    Blessing, JA
    Monk, BJ
    McGehee, R
    Moore, DH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) : 3340 - 3344
12345